Will blockbuster obesity drugs revolutionise addiction treatment?
Will blockbuster obesity drugs revolutionise addiction treatment? Summary Recent reports and early clinical trials suggest that GLP-1 receptor agonists — drugs such as semaglutide (Wegovy, Ozempic) and tirzepatide (Mounjaro, Zepbound)…
